|
SGOL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.433900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.846800E-01 |
| Normal-vs-Stage2 |
4.284200E-01 |
| Normal-vs-Stage3 |
5.102700E-03 |
| Normal-vs-Stage4 |
9.007800E-02 |
| Stage1-vs-Stage2 |
3.163400E-01 |
| Stage1-vs-Stage3 |
4.336500E-03 |
| Stage1-vs-Stage4 |
8.425600E-02 |
| Stage2-vs-Stage3 |
8.785500E-02 |
| Stage2-vs-Stage4 |
1.785560E-01 |
| Stage3-vs-Stage4 |
7.343200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.279630E-01 |
| Normal-vs-AfricanAmerican |
1.516970E-01 |
| Normal-vs-Asian |
1.599230E-01 |
| Caucasian-vs-AfricanAmerican |
7.183800E-01 |
| Caucasian-vs-Asian |
1.616760E-01 |
| AfricanAmerican-vs-Asian |
1.845010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.911200E-01 |
| Normal-vs-Female |
2.994100E-04 |
| Male-vs-Female |
5.992900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.038800E-01 |
| Normal-vs-Extreme_Weight |
9.746300E-02 |
| Normal-vs-Obese |
5.693500E-02 |
| Normal-vs-Extreme_Obese |
3.149600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.687700E-02 |
| Normal_Weight-vs-Obese |
6.374200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.465850E-01 |
| Extreme_Weight-vs-Obese |
5.659800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.229600E-01 |
| Obese-vs-Extreme_Obese |
3.074400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.307860E-02 |
| Normal-vs-Age(41-60Yrs) |
5.677900E-03 |
| Normal-vs-Age(61-80Yrs) |
9.309200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.893600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.512100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.398600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.117900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.970060E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.502190E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.715600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.302200E-01 |
| Normal-VS-Type2 PRCC |
1.948620E-01 |
| Normal-VS-KIRP CIMP |
3.583000E-03 |
| Normal-VS-Unclassified PRCC |
3.056000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.187040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.179200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.824400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.95190000000079E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.432600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.197000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.646600E-01 |
| Normal-vs-N1 |
1.766890E-04 |
| Normal-vs-N2 |
4.145000E-01 |
| N0-vs-N1 |
3.410700E-04 |
| N0-vs-N2 |
3.827400E-01 |
| N1-vs-N2 |
2.068200E-01 |
|
|
